McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue
+7.57%
EPS
+17.0%
Free cash flow
+32.5%
Total debt
+7.08%

Quarter to September 2026, against a year earlier

1,074.06 4.62 +0.43%
Market cap
$125.0B
P/E
27.5×
Fwd P/E
25.4×
Dividend yield
0.32%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100

McKesson Corporation 10-Q filed Feb 6, 2025

Fiscal Q3 2025 · Period ended Dec 31, 2024 · Filed · accepted 5:35 PM ET · Document on sec.gov · Filing index

Nothing in this filing raised a red flag. The document itself is on sec.gov.

Read the filing on sec.gov